Successes In Parkinsons Disease: Seeding Assays And Neurofilament Light Chains

Successes in Parkinson’s disease: seeding assays and neurofilament light chains

A-syn seeding assay: what is it and how can it support clinical trials? (Rallying 2023)

Cure Parkinson's

The association between neurofilament light chain and non-motor PD symptoms

α-synuclein seed amplification assay for diagnosing Parkinson's disease

Updates on α-synuclein as a biomarker in Parkinson's disease

NVJC Ep. 30 Parkinson Disease /Movement Disorders: Association of Neurofilament Light with PD

Neurology Journal

Time is brain in Parkinson's disease

Assessing the role of measuring plasma neurofilament light levels in ALS

Why is a staging system for Parkinson's so urgently needed? (Rallying 2023)

Cure Parkinson's

Advances in alpha-synuclein as a biomarker for Parkinson's disease

What the Parkinsons Disease Biomarker Breakthrough Means in Practice

α-Synuclein Seed Amplification in a Large Parkinson Cohort

Neurology Journal

Neurofilament Light Chain: A Mulitiple Sclerosis Biomarker (Dr. Marwa Kaisey Interview)

Dr. Brandon Beaber

Alpha-Synuclein and Parkinson’s disease: Part 2

Gates Brain Health

Peripheral α-synuclein as a Parkinson’s disease biomarker

Plasma NfL levels as a potential biomarker in MCI and Alzheimer’s disease

The current use of biomarkers in Parkinson’s disease

The Evolution of the Diagnosis of MSA - Anthony Lang, MD, FAAN

Defeat MSA Alliance Defeat Multiple System Atrophy

How should patients with Parkinson’s be subcategorized?

Alpha-Synuclein and Parkinson’s disease

Gates Brain Health